Dopamine Uptake Inhibitors

"Dopamine Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.

Descriptor ID	D018765
MeSH Number(s)	D27.505.519.562.437.220 D27.505.519.625.150.800 D27.505.519.625.600.220 D27.505.696.577.150.800 D27.505.696.577.600.220
Concept/Terms	Dopamine Uptake Inhibitors Dopamine Uptake Inhibitors Reuptake Inhibitors, Dopamine Inhibitors, Dopamine Uptake Uptake Inhibitors, Dopamine Inhibitors, Dopamine Reuptake Dopamine Reuptake Inhibitors

Below are MeSH descriptors whose meaning is more general than "Dopamine Uptake Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Neurotransmitter Uptake Inhibitors [D27.505.519.562.437]
Dopamine Uptake Inhibitors [D27.505.519.562.437.220]
Neurotransmitter Agents [D27.505.519.625]
Dopamine Agents [D27.505.519.625.150]
Dopamine Uptake Inhibitors [D27.505.519.625.150.800]
Neurotransmitter Uptake Inhibitors [D27.505.519.625.600]
Dopamine Uptake Inhibitors [D27.505.519.625.600.220]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Dopamine Agents [D27.505.696.577.150]
Dopamine Uptake Inhibitors [D27.505.696.577.150.800]
Neurotransmitter Uptake Inhibitors [D27.505.696.577.600]
Dopamine Uptake Inhibitors [D27.505.696.577.600.220]

Below are MeSH descriptors whose meaning is related to "Dopamine Uptake Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Dopamine Uptake Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dopamine Uptake Inhibitors" by people in this website by year, and whether "Dopamine Uptake Inhibitors" was a major or minor topic of these publications.

Bar chart showing 17 publications over 15 distinct years, with a maximum of 2 publications in 2010 and 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2003	0	1	1
2004	0	1	1
2005	1	0	1
2006	0	1	1
2008	1	0	1
2009	0	1	1
2010	1	1	2
2012	0	1	1
2013	0	1	1
2014	0	1	1
2015	1	1	2
2017	1	0	1
2018	1	0	1
2021	1	0	1

Below are the most recent publications written about "Dopamine Uptake Inhibitors" by people in Profiles.

Oakes HV, McWethy D, Ketchem S, Tran L, Phillips K, Oakley L, Smeyne RJ, Pond BB. Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism. Neurotox Res. 2021 Jun; 39(3):667-676.

View in: PubMed
Cotto B, Li H, Tuma RF, Ward SJ, Langford D. Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production. Neurobiol Dis. 2018 09; 117:28-41.

View in: PubMed
Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Curr Top Behav Neurosci. 2017; 32:93-117.

View in: PubMed
Schneider JS, Cambi F, Gollomp SM, Kuwabara H, Bra?ic JR, Leiby B, Sendek S, Wong DF. GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. J Neurol Sci. 2015 Sep 15; 356(1-2):118-23.

View in: PubMed
Dittrich HC, Feld GK, Bahnson TD, Camm AJ, Golitsyn S, Katz A, Koontz JI, Kowey PR, Waldo AL, Brown AM. COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm. Heart Rhythm. 2015 Jun; 12(6):1105-12.

View in: PubMed
Anizan S, Concheiro M, Lehner KR, Bukhari MO, Suzuki M, Rice KC, Baumann MH, Huestis MA. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Addict Biol. 2016 Mar; 21(2):339-47.

View in: PubMed
Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, Ancoli-Israel S, Reeve BB, Mustian K, O'Mara A, Lai JS, Fisch M, Cella D. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013 Oct 02; 105(19):1432-40.

View in: PubMed
Peterson JD, Bilyk JR, Sergott RC. But it's not all there. Surv Ophthalmol. 2013 Sep-Oct; 58(5):492-9.

View in: PubMed
Lloyd SA, Balest ZR, Corotto FS, Smeyne RJ. Cocaine selectively increases proliferation in the adult murine hippocampus. Neurosci Lett. 2010 Nov 19; 485(2):112-6.

View in: PubMed
O'Leary ME, Hancox JC. Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias. Br J Clin Pharmacol. 2010 May; 69(5):427-42.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement